Alpha Mannosidosis Market: Global Industry Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Alpha Mannosidosis Market Treatment Type (Bone Marrow Transplant, and Enzyme Replacement Therapy), Indication, (Type I, Type II, and Type III), End User (Hospitals, and Specialty Clinics) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

The alpha mannosidosis market is valued at USD billion in 2021 and is poised to grow at a significant CAGR of 17.8% over 2022–2028. The market is anticipated to expand during the forecast period due to rising research expenditures. Only one firm currently offers treatments for the rare hereditary illness alpha mannosidosis. However, several businesses are developing items that will drive up demand in the market throughout the projection period. For example, the EU clinical trials database includes 39,219 clinical trials with a EudraCT protocol in 2020, 6,426 of which involve participants under 18. Therefore, the alpha mannosidosis market is expanding due to rising research expenditures. The alpha mannosidosis market is starting to notice treatment innovations such as pharmaceutical therapy. For instance, the European Medicines Agency Committee for Medicinal Products for Human Use has approved Velmanase Alfa’s marketing authorization under the trade name Lamzede, according to Chiesi Group, a global healthcare firm focusing on research. To replace or supplement natural alpha-mannosidase, which aids in the breakdown of mannose-rich oligosaccharides and inhibits their build-up in various bodily tissues, Lamzede is an enzyme replacement therapy. Based on market trends, strategies for alpha mannosidosis include expanding enzyme therapy, implementing hematopoietic stem cell transplantation, and implementing cisterna magna infusion.

Alpha Mannosidosis Market

MARKET SUMMARY
-
18.6% CAGR
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR–17.8%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

Alpha Mannosidosis Market

  • The report on global alpha mannosidosis market gives historical, current, and future market sizes (US$ Mn) on the basis of treatment type, indication, end user, and geography.
  • The alpha mannosidosis market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Zymenex (Chiesi Farmaceutici S.p.A.)
  • Cytomedix Inc.
  • Natus
Alpha Mannosidosis Market Dynamics

Market exclusivity of orphan drugs, reimbursement for therapies, Regulatory support, incentives for orphan drug manufacturers, increase in investments in genetic therapies, growth in research and development, increase in healthcare spending, and market exclusivity of orphan drugs will all contribute to the market’s expansion. The coronavirus pandemic, high orphan medication, therapy costs, and reduced healthcare spending all impacted the industry.


Asia-Pacific Got Significant Share

Alpha Mannosidosis Market

The alpha mannosidosis market in Asia Pacific is likely to hold a significant revenue share in 2022, and, in the following years, it is predicted to increase rapidly. The dominance of North America is mainly related to the greater quantity of clinical trials carried out in the continent. Additionally, due to different government interventions, like the orphan drug act passed by the US federal government, the development of orphan pharmaceuticals grew throughout the region. Many orphan medications are receiving FDA and other regulatory body approvals due to such government policies.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The alpha mannosidosis market report provides granular level information about the market size, regional market share, historic market and forecast
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Alpha Mannosidosis Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The alpha mannosidosis market is projected to expand at a CAGR of 17.8% during the forecast period.

Chiesi Farmaceutici S.p.A., Nuo Therapeutics, Zymenex

Asia Pacific  is the fastest-growing region for alpha mannosidosis market


Report

Table Of Content

  1. Executive Summary
  2. Global Alpha Mannosidosis Market Introduction
    • Global Alpha Mannosidosis Market – Taxonomy
    • Global Alpha Mannosidosis Market –Definitions
      • Treatment Type
      • Indication
      • End User
  1. Global Alpha Mannosidosis Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Alpha Mannosidosis Market Dynamic Factors – Impact Analysis
    • Global Alpha Mannosidosis Market – Competition Landscape
  2. Global Alpha Mannosidosis Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Alpha Mannosidosis Market, By Treatment Type, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Bone Marrow Transplant (BMT)
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Enzyme Replacement Therapy (ERT)
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Alpha Mannosidosis Market, By Indication Type, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Type I
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Type II
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Type III
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Alpha Mannosidosis Market Forecast, By End User, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Hospitals
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Specialty Clinics
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Alpha Mannosidosis Market Forecast, By Region, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Alpha Mannosidosis Market – Opportunity Analysis Index, By Treatment Type, Indication, End User, and Region, 2019 – 2025
  2. North America Alpha Mannosidosis Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Treatment Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Bone Marrow Transplant (BMT)
      • Enzyme Replacement Therapy (ERT)
    • Indication Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Type I
      • Type II
      • Type III
    • End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Specialty Clinics
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Alpha Mannosidosis Market – Opportunity Analysis Index, By Treatment Type, Indication, End User, and Country, 2019 – 2025
    • North America Alpha Mannosidosis Market Dynamics – Trends
  3. Europe Alpha Mannosidosis Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Treatment Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Bone Marrow Transplant (BMT)
      • Enzyme Replacement Therapy (ERT)
    • Indication Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Type I
      • Type II
      • Type III
    • End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Specialty Clinics
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Alpha Mannosidosis Market – Opportunity Analysis Index, By Treatment Type, Indication, End User, and Country, 2019 – 2025
    • Europe Alpha Mannosidosis Market Dynamics – Trends
  4. Asia-Pacific Alpha Mannosidosis Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Treatment Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Bone Marrow Transplant (BMT)
      • Enzyme Replacement Therapy (ERT)
    • Indication Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Type I
      • Type II
      • Type III
    • End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Specialty Clinics
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Alpha Mannosidosis Market – Opportunity Analysis Index, By Treatment Type, Indication, End User, and Country, 2019 – 2025
    • Asia-Pacific Alpha Mannosidosis Market Dynamics – Trends
  5. Latin America Alpha Mannosidosis Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Treatment Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Bone Marrow Transplant (BMT)
      • Enzyme Replacement Therapy (ERT)
    • Indication Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Type I
      • Type II
      • Type III
    • End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Specialty Clinics
    • Other DiseasesCountry Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Alpha Mannosidosis Market – Opportunity Analysis Index, By Treatment Type, Indication, End User, and Country, 2019 – 2025
    • Latin America Alpha Mannosidosis Market Dynamics – Trends
  6. Middle East and Africa Alpha Mannosidosis Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Treatment Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Bone Marrow Transplant (BMT)
      • Enzyme Replacement Therapy (ERT)
    • Indication Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Type I
      • Type II
      • Type III
    • End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Specialty Clinics
    • Other DiseasesCountry Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Alpha Mannosidosis Market – Opportunity Analysis Index, By Treatment Type, Indication, End User, and Country, 2019 – 2025
    • MEA Alpha Mannosidosis Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Treatment Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Zymenex (Chiesi Farmaceutici S.p.A.)
      • Cytomedix Inc
  1. Research Methodology
  2. Key Assumptions and Acronyms

Report

Company Profile

  • Zymenex (Chiesi Farmaceutici S.p.A.)
  • Cytomedix Inc.
  • Natus

Description

The alpha mannosidosis market is valued at USD billion in 2021 and is poised to grow at a significant CAGR of 17.8% over 2022–2028. The market is anticipated to expand during the forecast period due to rising research expenditures. Only one firm currently offers treatments for the rare hereditary illness alpha mannosidosis. However, several businesses are developing items that will drive up demand in the market throughout the projection period. For example, the EU clinical trials database includes 39,219 clinical trials with a EudraCT protocol in 2020, 6,426 of which involve participants under 18. Therefore, the alpha mannosidosis market is expanding due to rising research expenditures. The alpha mannosidosis market is starting to notice treatment innovations such as pharmaceutical therapy. For instance, the European Medicines Agency Committee for Medicinal Products for Human Use has approved Velmanase Alfa’s marketing authorization under the trade name Lamzede, according to Chiesi Group, a global healthcare firm focusing on research. To replace or supplement natural alpha-mannosidase, which aids in the breakdown of mannose-rich oligosaccharides and inhibits their build-up in various bodily tissues, Lamzede is an enzyme replacement therapy. Based on market trends, strategies for alpha mannosidosis include expanding enzyme therapy, implementing hematopoietic stem cell transplantation, and implementing cisterna magna infusion.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX